ArticleOman medical journal2022

Overall Survival Prediction of Docetaxel-based Second-line Treatment for Advanced Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis.

Chaitra Nagaraju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.